1.
Surveillance of serotypes and antimicrobial susceptibility profile in group B streptococcus (GBS) in Belgium
2.
3.
Phenotypical and genotypical surveillance of macrolide and lincosamide resistance in group B streptococcus in Belgium
VALIDATION, IMPLEMENTATION AND ROUTINE WORK WITH TOTAL LAB-AUTOMATION BD-KIESTRA : A TWO-YEAR EXPERIENCE AT THE UNIVERSITY HOSPITAL OF LIÈGE, BELGIUM
2015 Surveillance of Group B Streptococcus strains isolated from invasive diseases among adults in Belgium : bacteriological and clinical characteristics.
4.
5.
6.
7.
Clinical impact of a direct Rapid Antimicrobial Susceptibility Testing (dRAST) in administration of optimal therapy in patients with bloodstream infection ; Belgique
Update of the characteristics of Group B Streptococci (GBS) colonizing pregnant women in Belgium: capsular-type distribution, pili characterization, antimicrobial susceptibility pr...
Group B streptococcus neonatal invasive infections in Belgium 2010-2017, and characterization of isolated strains.
Group B Streptococcus neonatal invasive infections in Belgium, 2013-2016
Characterization of Group B Streptococcus strains isolated from neonatal invasive diseases in Belgium, 2015.